Cytotoxic Effect of Resveratrol on Colorectal Cancer Cell Line
Article Sidebar
Main Article Content
Abstract
This study aimed to examine the cytotoxic effect of resveratrol as an anticancer in human colorectal cancer (HRT) cell line by assessment of its half-maximal inhibitory concentration (IC50) and its ability to inhibit the growth of these cancerous cells. Resveratrol inhibited the proliferation of HRT cell lines when used at different increased concentrations in this study (25, 50, 100, 200, and 300 μmol). These increased concentrations of resveratrol caused a corresponding significant inhibition in the growth percentage of the tested cancerous cell line (13%, 31.33%, 53.66%, 63.66 %, and 76.33%, respectively) when compared with DMSO0.1% as negative control, in a concentration-dependent manner. Resveratrol at 300 μmol concentration showed the highest significant increase in the growth inhibitory percentage (76.33%). Moreover, resveratrol IC50 against HRT cell line was determined as 75.63 μmol. The study suggests a promising anticancer activity of resveratrol, which can interfere with many dysregulated signaling pathways in transformed cells which are proposed to be driving forces for its anticancer effect.
Downloads
Article Details
How to Cite
References
Lee SY, Haq F, Kim D, Jun C Jo HJ, Ahn SM, et al. Comparative genomic analysis of primary and synchronous metastatic colorectal cancers. PloS One. 2014; 5,9 (3): 59-90.
Dušek L, Mužík J, Malúšková D, Šnajdrová L. Epidemiology of colorectal cancer: international comparison [online]. Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno Czech Republic.2015;1,1402.
Rasool S, Rasool V, Naqvi T, Ganai BA, Shah BA. Genetic unraveling of colorectal cancer. Tumour Biology: Tumour Biol. 2014;17(5):1-4.
Steward WP, Brown K. Cancer chemoprevention: a rapidly evolving field.Br. J. Cancer. 2013; 109: 1-7.
Hasanpour M, Galehdari H, Masjedizadeh A, Ajami N. A unique profile of adenomatous polyposis coli gene mutations in Iranian patients suffering sporadic colorectal cancer. Cell J.2014; 16: 17-24.
Steinke V, Engel C, Buttner R, Schackert HK, Schmiegel WH, Propping P. Hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome. DTSCH ARZTEBL INT. 2013; 110: 32-38.
Fostira F, Thodi G, Konstantopoulou I, Sandaltzopoulos R, Yannoukakos D. Hereditary cancer syndromes. Journal of B.U.ON.2007;1: 13-22.
Wang Z, Chen Y, Wu B, Zheng H, He J, Jiang B. A novel mutation in STK11 gene is associated with Peutz-Jeghers syndrome in Chinese patients. BMCMEDGENET. 2011; 12:12-161.
Mishra RN. Resveratrol -the new rasayan (antiaging) drug. BMC Complement Med Ther.2011; 1: 5-18.
Whitehead TP, Robinson D, Allaway S, Syms J, Hale A. Effect of red wine ingestion on the antioxidant capacity of serum. ClinChem Lab Med.1995; 41: 32-35.
Blanco-Colio LM, Valderrama M, Alvarez-Sala LA, Bustos C, Ortego M, Hernandez-Presa MA, et al. Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia. Circulation. pubmed.2000; 102: 1020-1026.
Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov.2006; 5: 493-506.
Bode LM, Bunzel D, Huch M, Cho GS, Ruhland D, Bunzel M. et al. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am J ClinNutr.2013; 97: 295-309.
Storniolo CE, Moreno JJ. Resveratrol metabolites have an antiproliferative effect on intestinal epithelial cancer cells. Food Chem X.2012; 134: 1385-1391.
Tomé-Carneiro J, Larrosa M, Gonzalez-Sarrias A, Tomas-Barberan FA, Garcia-Conesa MT, Espin JC. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Current Pharmaceutical Design.2013; 19: 6064-6093.
Wolter F, Akoglu B, Clausnitzer A, Stein J. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J ClinNutr Food Sci. 2001; 131: 2197-2203.
Sulaiman GM, Jabir MS, Hameed AH. Nanoscale modification of chrysin for improved of therapeutic efficiency and cytotoxicity. Arificial Artif Cells Nanomed Biotechnol. 2018;1: 1-8.
Jabir MS, Taha AA, Sahib UI, Taqi ZJ, Al-Shammari AM, Salman AS. Novel of nano delivery system for linalool loaded on gold nanoparticles conjugated with CALNN peptide for application in drug uptake and induction of cell death on breast cancer cell line, Mater. Sci. Eng. C.2019; 94:949-964.
Jabir MS, Sulaiman GM, Taqi ZJ, Li D. Iraqi propolis increases degradation of IL-1β and NLRC4 by autophagy following Pseudomonas aeruginosa infection, Microb Infect.2018;20: 89-100.
Longe JL. The Gale Encyclopedia of Medicine. 3rd ed Thompson Gale Corporation 2006; 2:939.
Geller E, Editors. Encyclopedia of Science and Technology. New York: McGraw-Hill. 2020. 3:424p.
Manhal FA . Cytotoxic effect of green tea leaf extract on tumor cell line. Iraqi .J.Vet.Med.2017; 41(1):71-75.
Tripodo G, Mandracchia D, Collina S, Rui M, Rossi D. New perspectives in cancer therapy: the biotin-antitumor molecule conjugates. Med chem, an open access. 2014; S1(004):1-8.
Sun W, Wang W, Kim J. Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment. Adv Exp Med Biol. 2008; 614:179-86.
Whyte L, Huang YY, Torres K, Mehta RG. Molecular mechanism of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res. 2007; 67:12007-17.
Fulda S, Debatin KM. Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene.2004;23: 6702-6711.
Amiri F, Zarnani AH, Zand H, Koohdani F, Jeddi-Tehrani M, Vafa M. Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines. Eur. J. Pharmacol. 2013; 718(1-3): 34-40.
Santandreu F M, Valle A, Oliver J, Roca P. Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells. Cell. Physiol. Biochem. 2011; 28: 219-228.
Mohapatra P, Preet R, Choudhuri M, Choudhuri T, Kundu C N. 5-fluorouracil increases the chemopreventive potentials of resveratrol through DNA damage and MAPK signaling pathway in human colorectal cancer cells. Oncol. Re.2011; 19: 311–321.
Hwang JT, Kwak D W, Lin S K, Kim H M, Kim YM, Park OJ. Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway. Ann. N.Y. Acad. Sci. 2007;1095: 441-448.